Bard Hernia Mesh
Plain-English guide to Bard hernia mesh lawsuits, MDL-2846 status, alleged chronic pain and revision surgery claims, evidence, deadlines, and settlement posture.
This guide is for general information only. It does not provide legal advice, does not create an attorney-client relationship, and case status can change.
Lawsuit status — September 2026
Bard Hernia Mesh Lawsuit
Verified September 14, 2026
- MDL
- MDL-2846
- Court
- S.D. Ohio
- Judge
- Judge Edmund A. Sargus, Jr.
- Pending cases
- 23,316
- -5 since prior report
- Current phase
- Settlement administration and unresolved-claim process
- Settlement status
- settlement administration
- Latest development
- JPML reports 23,316 pending actions and 25,213 historical actions in MDL-2846.
- Next major event
- January 4, 2027 — Intensive Settlement Process target start
What changed this month?
- ●JPML reports 23,316 pending actions and 25,213 historical actions in MDL-2846. Source
- ●Pending actions decreased by 5 from 23,321 on August 3, 2026. This is a net docket change, not a count of new claims. Source
- ●CMO 56 established a qualified settlement fund for eligible settling claimants. Source
- ●CMO 55 schedules unresolved-claim settlement sessions to begin on or about January 4, 2027. Source
What the lawsuit is about
The Bard hernia mesh lawsuit alleges that certain Davol/C.R. Bard polypropylene hernia mesh products caused chronic pain, infection, adhesions, recurrence, bowel complications, mesh failure, or revision surgery. Federal cases are coordinated in MDL-2846 before Judge Edmund A. Sargus, Jr. in the U.S. District Court for the Southern District of Ohio. Defendants dispute the allegations.
As of September 1, 2026, the JPML reported 23,316 pending actions in MDL-2846, making Bard hernia mesh one of the largest active product-liability MDLs.
Bard Hernia Mesh Lawsuit update: September 2026
Settlement administration and unresolved-claim process. Court orders establish a settlement fund and a separate Intensive Settlement Process for unresolved claims. CMO 55 schedules that process to begin on or about January 4, 2027. The September 2026 JPML report still lists 23,316 pending actions; pending cases are not proof that every claimant has settled or been paid.
The JPML, September 1, 2026 lists 23,316 pending actions and 25,213 total historical actions. The figures are docket counts, not settlement eligibility or payment counts.
Settlement status: CMO 56 established a qualified settlement fund for eligible settling claimants. CMO 55 provides settlement conferences and mediation for defined unresolved claimants beginning on or about January 4, 2027. The orders reviewed do not publish a total settlement amount or a uniform individual payment.
What changed this month?
- JPML reports 23,316 pending actions and 25,213 historical actions in MDL-2846. Source
- Pending actions decreased by 5 from 23,321 on August 3, 2026. This is a net docket change, not a count of new claims. Source
- CMO 56 established a qualified settlement fund for eligible settling claimants. Source
- CMO 55 schedules unresolved-claim settlement sessions to begin on or about January 4, 2027. Source
Case Status Snapshot
- Status: Active / Investigating
- Primary injuries: Chronic pain, infection, adhesions, recurrence, bowel complications, and revision surgery
- MDL: MDL-2846, Southern District of Ohio
- Pending actions: 23,316 as of September 1, 2026
- Settlement status: Settlement activity exists, but no single public global amount resolves every claim
- Deadline: Varies by state and by implant, complication, discovery, and revision dates
Who may qualify for a Bard hernia mesh lawsuit?
There is no automatic qualification rule. A review may consider whether a Bard or Davol hernia mesh product was implanted, whether records identify the product, what complication occurred, whether revision or removal surgery was needed, and whether the timeline fits the claim being evaluated.
Commonly reviewed facts include implant date, hernia type, product name, symptoms, recurrence, infection, adhesions, bowel complications, and any revision or explant procedure.
What proof may help a hernia mesh claim?
Useful records may include the implant operative report, product sticker page, hospital supply record, follow-up treatment notes, imaging, infection records, revision surgery reports, and pathology or explant records if mesh was removed.
Because patients often do not know the product name, operative records and hospital device sticker sheets can be especially important. Records showing repeated treatment, ongoing pain, recurrence, or revision surgery may help document the injury timeline.
Hernia mesh lawsuit deadline considerations
Deadlines vary by state and may depend on implant date, when complications appeared, when a doctor identified mesh as a possible cause, revision date, and whether the case involves personal injury or wrongful death. Some people have mesh implanted years before complications become clear, which can make discovery-rule analysis important.
Anyone researching a possible claim should gather implant date, product identification, first complication date, revision or removal date, and any medical note linking symptoms to mesh.
Sources and status notes
- MDL count: Pending-action counts come from the JPML Pending MDL Dockets report dated September 1, 2026.
- Related MDLs & trials: Other hernia mesh MDLs — Covidien/Medtronic (MDL-3029) and Atrium C-QUR (MDL-2753) — appear on the JPML's pending-MDL list. MDL-2846 bellwether outcomes (a defense verdict in Johns; an approximately $255,000 award in Milanesi) are matters of public court record.
- Litigation status: This guide summarizes public information and should not be treated as a live docket report or legal advice.
- Review note: Product identification and revision-surgery records are often central in hernia mesh claims.
Where can I track the Bard Hernia Mesh lawsuit?
Use the mass tort settlement tracker to compare public settlement posture, the deadline tracker for filing-window and key-date notes , and the MDL statistics tracker for federal case counts and court assignments.
What injuries does the Bard Hernia Mesh lawsuit involve?
- Chronic pain
- Infection
- Adhesions
- Hernia recurrence
- Bowel obstruction or perforation allegations
- Revision or removal surgery
How has the Bard Hernia Mesh lawsuit progressed?
Mesh implant
Claim review usually begins with implant records identifying the hernia mesh product and surgery date.
Complication or revision
Medical records may document chronic pain, infection, adhesions, recurrence, bowel complications, or revision/removal surgery.
Claim review
A lawyer may compare product identification and injury records with MDL-2846 status and state filing deadlines.
What is the Bard Hernia Mesh settlement status?
The Bard hernia mesh MDL has involved settlement activity and individual case resolution, but no single court-approved public global settlement amount resolves every claim. Case value and eligibility depend on product identification, injury severity, revision surgery, causation, and individual facts. Defendants dispute liability and causation.
State-by-state guide links
Frequently Asked Questions
What is the Bard hernia mesh lawsuit about?
Bard hernia mesh lawsuits allege that certain polypropylene hernia mesh products were defectively designed or inadequately warned about and caused injuries such as chronic pain, infection, adhesions, recurrence, bowel complications, or revision surgery. Defendants dispute the allegations.
Where are federal Bard hernia mesh cases handled?
Federal Bard hernia mesh cases are coordinated in MDL-2846 before Judge Edmund A. Sargus, Jr. in the Southern District of Ohio.
How many Bard hernia mesh lawsuits are pending?
The JPML's September 1, 2026 report listed 23,316 pending actions in MDL-2846. The count can change monthly.
Is there a Bard hernia mesh settlement?
The litigation has involved settlement activity and individual case resolution, but no single court-approved public global settlement amount resolves every claim. Outcomes depend on product, injury, records, and litigation posture.
How much are Bard hernia mesh settlements worth?
There is no published per-person amount, and any figure presented online as an 'average hernia mesh payout' is speculation. Value in an individual case depends on product identification, injury severity, whether revision or removal surgery was required, causation proof, and state law. Early MDL bellwether trials produced mixed results — a defense verdict in the first (Johns v. Becton Dickinson) and plaintiff verdicts in later cases (for example, about $255,000 in Milanesi) — and past results do not predict any individual outcome. No amount is guaranteed.
Is the Bard hernia mesh lawsuit a class action?
No. Federal Bard hernia mesh cases are coordinated as multidistrict litigation (MDL-2846), where each plaintiff keeps an individual claim grouped for pretrial proceedings — unlike a class action, where one outcome binds the whole group.
When will the Bard hernia mesh lawsuit be settled?
There is no universal payment date. Court orders establish a qualified settlement fund and an Intensive Settlement Process for defined unresolved claims, targeted to begin on or about January 4, 2027. Timing and eligibility remain claim-specific, and nothing is guaranteed.
Are other hernia mesh brands part of this lawsuit?
Not this MDL. This guide covers Bard/Davol polypropylene mesh (MDL-2846). Other manufacturers face separate proceedings, including Covidien/Medtronic hernia mesh (MDL-3029) and Atrium C-QUR (MDL-2753). Product identification matters because each manufacturer's cases proceed separately.
What proof may help a hernia mesh claim?
Helpful records may include implant records, device stickers, operative reports, revision surgery records, imaging reports, infection records, and records showing recurrence, adhesions, bowel complications, or chronic pain.
Do state deadlines matter?
Yes. Deadlines vary by state and may depend on implant date, complication date, discovery facts, revision date, wrongful-death issues, and other facts.
Related Lawsuits
Sources and Update Log
- Last reviewed
- September 14, 2026
- Last updated
- September 14, 2026